Stories from the dialysis comunity across the globe.
|
RPA: Write your Congressperson to support extended immunosuppressive drug coverage for transplant patients. |
|
|
RPA: Action Alert. Support Immunosuppressive Drug Coverage for Kidney Transplant Patients. All RPA members should contact their elected representatives in Washington to urge them to support the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (S. 1454, H.R. 2969) to extend coverage of immunosuppressive drugs for kidney transplant recipients.
|
|
Daily vibration combats prediabets in young mice. |
|
|
Science Blog: In mice that mimic over-eating adolescents headed toward diabetes, 20 minutes of daily vibration for eight weeks restored a healthy balance of key pro- and anti-inflammatory mediators and was better than prescription drugs at reducing levels of hemoglobin A1c, the most accurate indicator of average blood glucose levels, said Dr. Jack C. Yu, Chief of the Section of Plastic and Reconstructive Surgery at the Medical College of Georgia at Georgia Health Sciences University.
|
Bardoxolone study terminated by safety monitoring committee. |
|
|
Yahoo: Abbott Laboratories Inc said its partner, Reata Pharmaceuticals, was discontinuing a late-stage trial of their potential blockbuster treatment for chronic kidney disease and diabetes based on safety concerns raised by an independent safety committee.
|
|
Egg freezing works to preserve fertility. |
|
|
Boston.com: Here’s good news for women who are thinking about freezing eggs from their ovaries because they’re not ready to have a baby -- and are worried that they’ll be too old when they are -- or are undergoing chemotherapy or radiation that might render them infertile. The technique really does work to achieve successful pregnancies and should no longer be considered experimental, according to new guidelines set to be issued Monday by the American Society for Reproductive Medicine.
|
Vitamin D supplements may benefit lupus patients |
|
|
EurekAlert: In a prospective clinical trial, Nathalie Costedoat-Chalumeau and colleagues set out to evaluate the safety and immunological effects of vitamin D supplementation in 20 SLE patients with low vitamin D levels. They observed these patients over six months and found that vitamin D was not only well-tolerated but, more importantly, there were no SLE flare-ups during the follow-up period. Vitamin D supplementation in these patients caused an increase in beneficial CD4+ cells (mature Th cells), an increase in Treg cells and a decrease of effector Th1 and Th17 cells. It also induced a decrease of memory B cell and anti-DNA antibodies – all beneficial for SLE symptoms. The authors found that no modification of existing immunosuppressant drugs was needed, nor any new drugs initiated.
|
|
|
|
<< Start < Prev 461 462 463 464 465 466 467 468 469 470 Next > End >>
|
Page 463 of 4210 |